• LAST PRICE
    1.2800
  • TODAY'S CHANGE (%)
    Trending Up0.0100 (0.7874%)
  • Bid / Lots
    1.2300/ 2
  • Ask / Lots
    1.3000/ 7
  • Open / Previous Close
    1.2300 / 1.2700
  • Day Range
    Low 1.2300
    High 1.3200
  • 52 Week Range
    Low 0.6220
    High 2.5000
  • Volume
    161,317
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 1.27
TimeVolumeITRM
09:32 ET50321.27
09:35 ET1001.27
09:37 ET2891.2649
09:44 ET36161.2301
09:46 ET22001.23
09:48 ET2001.26
09:50 ET4001.26
10:00 ET33001.275
10:02 ET88711.3
10:04 ET79121.29
10:06 ET4001.3
10:11 ET17941.3
10:13 ET7001.3
10:15 ET5001.3025
10:18 ET32201.3
10:20 ET1001.3
10:22 ET38001.3
10:27 ET1001.3025
10:31 ET8001.3
10:33 ET3231.305
10:38 ET7001.3
10:40 ET2001.3
10:44 ET1121.2912
10:47 ET259551.29
10:49 ET24001.28
10:56 ET10001.28
11:02 ET30001.3
11:03 ET1001.3
11:05 ET2001.3
11:07 ET48041.3
11:21 ET2001.3
11:32 ET104251.27
11:34 ET3001.28
11:38 ET15811.29
11:50 ET2461.3
11:52 ET26001.3
11:54 ET1651.2902
11:56 ET1001.29
11:57 ET8461.29
12:01 ET1191.2902
12:03 ET1001.31
12:06 ET103001.3
12:17 ET1001.3
12:21 ET6941.3025
12:26 ET1001.3025
12:33 ET7001.3
12:37 ET1881.3
12:39 ET19001.3
12:42 ET1001.3025
12:44 ET39001.31
12:46 ET45001.3
12:53 ET30161.2919
01:00 ET5551.3
01:02 ET4531.3
01:04 ET1001.29
01:11 ET11501.3075
01:15 ET3001.3
01:24 ET13001.3
01:26 ET1001.3
01:27 ET8331.3001
01:31 ET1001.3
01:42 ET1001.3
01:49 ET1001.3
01:51 ET2001.3
01:54 ET1001.3025
01:58 ET1001.32
02:03 ET1001.3
02:16 ET2001.307
02:34 ET21001.305
02:36 ET5001.3
02:38 ET6271.3
02:41 ET1001.3
02:43 ET1001.3
02:52 ET3451.2999
02:56 ET1001.3
02:59 ET52001.3
03:08 ET1001.3
03:14 ET3001.3
03:17 ET2001.3
03:19 ET5001.3
03:35 ET1091.3
03:39 ET1021.3
03:42 ET2001.3
03:44 ET17501.3
03:46 ET6001.3
03:51 ET4001.3
03:53 ET8011.305
03:55 ET2461.3
03:57 ET8171.3
04:00 ET6061.28
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesITRM
Iterum Therapeutics PLC
17.1M
-0.5x
---
United StatesBCLI
Brainstorm Cell Therapeutics Inc
17.1M
-0.8x
---
United StatesBIXT
Bioxytran Inc
16.9M
-3.5x
---
United StatesMBOT
Microbot Medical Inc
16.9M
-1.0x
---
United StatesNBIO
Nascent Biotech Inc
16.8M
-6.4x
---
United StatesNRSN
Neurosense Therapeutics Ltd
17.4M
-1.6x
---
As of 2024-02-26

Company Information

Iterum Therapeutics plc is a clinical-stage pharmaceutical company. The Company develops differentiated anti-infectives aimed at combatting the global crisis of multi-drug resistant pathogens to significantly improve the lives of people affected by serious and life-threatening diseases around the world. It is advancing its first compound, sulopenem, a novel penem anti-infective compound, in Phase 3 clinical development with an oral formulation. Sulopenem is a potent, thiopenem antibiotic delivered intravenously, which is active against bacteria that belong to the group of organisms known as gram-negatives and causes urinary tract and intra-abdominal infections. It has also developed sulopenem in an oral tablet formulation, sulopenem etzadroxil-probenecid. Sulopenem also has an IV formulation. Sulopenem has demonstrated potent in vitro activity against a variety of gram-negative, gram-positive and anaerobic bacteria resistant to other antibiotics.

Contact Information

Headquarters
Fitzwilliam Court 1st Floor, Leeson Close, Dublin 2DUBLIN, Ireland D02 YW24
Phone
---
Fax
---

Executives

Independent Chairman of the board
Brenton Ahrens
President, Chief Executive Officer, Director
Corey Fishman
Chief Financial Officer
Judith Matthews
Chief Medical Officer
Sailaja Puttagunta
Director
Michael Dunne

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$17.1M
Revenue (TTM)
$0.00
Shares Outstanding
13.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.36
EPS
$-2.44
Book Value
$2.22
P/E Ratio
-0.5x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.